Owen N. Witte - 13 Jun 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/Lillian Smith, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
13 Jun 2023
Net transactions value
$0
Form type
4
Filing time
15 Jun 2023, 17:00:10 UTC
Previous filing
15 Aug 2022
Next filing
07 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +74,561 +34% $0.000000 292,832 13 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.